Clinical Trials Browser

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Mesothelioma, Ovarian Neoplasms, Stomach Neoplasms, Small Cell Lung Carcinoma, Triple Negative Breast Neoplasms

NCT00019565 2016-09-26

PET and/or MRI Scans in Assessing Tumor Response in Patients Receiving Antiangiogenesis Therapy

Phase 1 Completed

53 enrolled

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00006981 2015-04-30

Immunotoxin Therapy in Treating Patients With Advanced Cancer

Phase 1 Completed

GastrointestinalGynecologicHead & NeckOther solid neoplasmThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Ovarian Epithelial, Mesothelioma, Malignant, Brenner Tumor, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Fallopian Tube Neoplasms, Head and Neck Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Salivary Gland Neoplasms

NCT00020488 2015-04-30

Combination Chemotherapy in Treating Patients Who Have Advanced Solid Tumors

Phase 1 Completed

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00042861 2015-04-30

UCN-01, Fluorouracil, and Leucovorin in Treating Patients With Metastatic or Unresectable Solid Tumors

Phase 1 Completed

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00066651 2015-04-30

Immunotoxin Therapy in Treating Patients With Advanced Solid Tumors

Phase 1 Completed

GastrointestinalGynecologicHead & NeckOther solid neoplasmThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Ovarian Epithelial, Mesothelioma, Malignant, Brenner Tumor, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Fallopian Tube Neoplasms, Head and Neck Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Salivary Gland Neoplasms

NCT00072111 2015-04-30

Anakinra in Treating Patients With Metastatic Cancer Expressing the Interleukin-1 Gene

Phase 1 Completed

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00019357 2015-04-29

Interleukin-2 Plus Activated White Blood Cells in Treating Patients With Cancer That Has Not Responded to Chemotherapy or Radiation Therapy

Phase 1 Completed

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00019825 2015-04-29

Decitabine in Treating Patients With Unresectable Lung or Esophageal Cancer or Malignant Mesothelioma of the Pleura

Phase 1 Completed

GastrointestinalOther solid neoplasmThoracic

Mesothelioma, Malignant, Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms, Lung Neoplasms, Neoplasm Metastasis, Pleural Effusion, Malignant, Small Cell Lung Carcinoma

NCT00021216 2015-04-15

Bortezomib in Treating Children With Advanced Solid Tumors

Phase 1 Completed

36 enrolled

Other solid neoplasm

Unspecified Childhood Solid Tumor, Protocol Specific

NCT00255658 2015-04-15

Sorafenib and Temsirolimus in Treating Patients With Unresectable or Metastatic Solid Tumors

Phase 1 Completed

40 enrolled

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00567931 2014-07-24

1-Methyl-D-Tryptophan in Treating Patients With Metastatic or Refractory Solid Tumors That Cannot Be Removed By Surgery

Phase 1 Completed

52 enrolled

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00121264 2014-06-17

17-AAG and Sorafenib in Treating Patients With Unresectable or Metastatic Solid Tumors

Phase 1 Completed

54 enrolled

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00415324 2014-05-20

Eribulin Mesylate and Cisplatin in Treating Patients With Advanced Solid Tumors

Phase 1 Completed

36 enrolled

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT01240538 2014-05-13

Viral Therapy in Treating Young Patients With Relapsed or Refractory Solid Tumors

Phase 1 Completed

26 enrolled

Other solid neoplasm

Unspecified Childhood Solid Tumor, Protocol Specific

NCT00880282 2014-04-29

Cixutumumab and Temsirolimus in Treating Younger Patients With Solid Tumors That Have Recurred or Not Responded to Treatment

Phase 1 Completed

39 enrolled

Other solid neoplasm

Unspecified Childhood Solid Tumor, Protocol Specific

NCT01141244 2014-04-10

Temsirolimus, Irinotecan Hydrochloride, and Temozolomide in Treating Younger Patients With Relapsed or Refractory Solid Tumors

Phase 1 Completed

72 enrolled

Other solid neoplasm

Unspecified Childhood Solid Tumor, Protocol Specific

NCT00544596 2014-04-02

R-(-)-Gossypol Acetic Acid, Cisplatin, and Etoposide in Treating Patients With Advanced Solid Tumors or Extensive Stage Small Cell Lung Cancer

Phase 1 Completed

27 enrolled

Other solid neoplasmThoracic

Extensive Stage Small Cell Lung Cancer

NCT01096355 2014-04-02

Gamma-Secretase Inhibitor RO4929097 in Treating Patients With Metastatic or Unresectable Solid Malignancies

Phase 1 Completed

28 enrolled

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00046917 2014-02-24

Combination Chemotherapy in Treating Patients With Advanced Solid Tumors

Phase 1 Completed

13 enrolled

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00112684 2014-02-24

Alvocidib in Treating Patients With Locally Advanced or Metastatic Solid Tumors

Phase 1 Terminated

25 enrolled

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00121290 2014-02-24

SJG-136 in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed By Surgery

Phase 1 Completed

39 enrolled

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00227513 2014-02-24

Vorinostat and Bortezomib in Treating Patients With Metastatic or Unresectable Solid Tumors

Phase 1 Completed

66 enrolled

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00324480 2014-02-24

Vorinostat and Alvocidib in Treating Patients With Advanced Solid Tumors

Phase 1 Completed

60 enrolled

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00357318 2014-02-24

Bevacizumab and Sunitinib in Treating Patients With Solid Tumors

Phase 1 Completed

60 enrolled

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00436579 2014-02-24

Sorafenib in Treating Patients With Advanced Solid Tumors

Phase 1 Terminated

110 enrolled

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00701298 2014-02-24

Decitabine With or Without Interferon Alfa-2b in Treating Patients With Unresectable or Metastatic Solid Tumors

Phase 1 Terminated

30 enrolled

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00387920 2014-01-28

Sunitinib in Treating Young Patients With Refractory Solid Tumors

Phase 1 Completed

35 enrolled

CNSOther solid neoplasm

Central Nervous System Metastases

NCT00003697 2013-12-19

Dimethylxanthenone Acetic Acid in Treating Patients With Solid Tumors

Phase 1 Completed

3 enrolled

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00003698 2013-12-19

Chemotherapy in Treating Patients With Solid Tumors

Phase 1 Completed

35 enrolled

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00004051 2013-12-19

Irinotecan in Treating Patients With Advanced Solid Tumors

Phase 1 Completed

40 enrolled

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00004076 2013-12-19

PNU 166148 in Treating Patients With Metastatic Solid Tumors

Phase 1 Unknown

30 enrolled

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00005791 2013-12-19

Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Solid Tumors

Phase 1 Completed

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00005996 2013-12-19

SU5416 Combined With Gemcitabine and Cisplatin in Treating Patients With Advanced Solid Tumors

Phase 1 Unknown

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00436761 2013-12-18

Busulfan, Melphalan, and Antithymocyte Globulin Followed By Umbilical Cord Blood Transplant in Treating Young Patients With Refractory or Relapsed Malignant Solid Tumors

Phase 1 Unknown

20 enrolled

Other solid neoplasm

Unspecified Childhood Solid Tumor, Protocol Specific

NCT00080990 2013-12-16

Alvocidib, Oxaliplatin, Fluorouracil, and Leucovorin Calcium in Treating Patients With Advanced Solid Tumors

Phase 1 Completed

46 enrolled

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

Clinical Trials

Veliparib and Dinaciclib in Treating Patients With Advanced Solid Tumors

Entinostat, Nivolumab, and Ipilimumab in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery or Locally Advanced or Metastatic HER2-Negative Breast Cancer

Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial Cancer

Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma

Atezolizumab, Pemetrexed Disodium, Cisplatin, and Surgery With or Without Radiation Therapy in Treating Patients With Stage I-III Pleural Malignant Mesothelioma

Liposomal Irinotecan and Veliparib in Treating Patients With Solid Tumors

Intratumor Injection of Anti-Mesothelin Immunotoxin LMB-100 With Ipilimumab in Malignant Mesothelioma

Phase I Evaluation of Immunotoxin LMB-100 Administered by Normothermic, Intrapleural Perfusion Following Cytoreductive Surgery in Participants With Pleural Mesotheliomas, or Pleural Effusions From Cancers Expressing Mesothelin

Pilot Study of Allogeneic Tumor Cell Vaccine With Metronomic Oral Cyclophosphamide and Celecoxib in Patients Undergoing Resection of Lung and Esophageal Cancers, Thymic Neoplasms, and Malignant Pleural Mesotheliomas

Depsipeptide/Flavopiridol Infusion for Cancers of the Lungs, Esophagus, Pleura, Thymus or Mediastinum

Tumor Cell Vaccines With ISCOMATRIX Adjuvant and Celecoxib in Patients Undergoing Resection of Lung and Esophageal Cancers and Malignant Pleural Mesotheliomas

Mesothelin-Targeted Immunotoxin LMB-100 in Combination With SEL-110 in Subjects With Malignant Pleural or Peritoneal Mesothelioma

Phase I Study of Gene Induction Mediated by Sequential Decitabine/Depsipeptide Infusion With or Without Concurrent Celecoxib in Subjects With Pulmonary and Pleural Malignancies

SS1(dsFV)PE38 Plus Pemetrexed and Cisplatin to Treat Malignant Pleural Mesothelioma

Talazoparib in Treating Patients With Advanced or Metastatic Solid Tumors That Cannot Be Removed by Surgery and Liver or Kidney Dysfunction

PET and/or MRI Scans in Assessing Tumor Response in Patients Receiving Antiangiogenesis Therapy

Immunotoxin Therapy in Treating Patients With Advanced Cancer

Combination Chemotherapy in Treating Patients Who Have Advanced Solid Tumors

UCN-01, Fluorouracil, and Leucovorin in Treating Patients With Metastatic or Unresectable Solid Tumors

Immunotoxin Therapy in Treating Patients With Advanced Solid Tumors

Anakinra in Treating Patients With Metastatic Cancer Expressing the Interleukin-1 Gene

Interleukin-2 Plus Activated White Blood Cells in Treating Patients With Cancer That Has Not Responded to Chemotherapy or Radiation Therapy

Decitabine in Treating Patients With Unresectable Lung or Esophageal Cancer or Malignant Mesothelioma of the Pleura

Bortezomib in Treating Children With Advanced Solid Tumors

Sorafenib and Temsirolimus in Treating Patients With Unresectable or Metastatic Solid Tumors

1-Methyl-D-Tryptophan in Treating Patients With Metastatic or Refractory Solid Tumors That Cannot Be Removed By Surgery

17-AAG and Sorafenib in Treating Patients With Unresectable or Metastatic Solid Tumors

Eribulin Mesylate and Cisplatin in Treating Patients With Advanced Solid Tumors

Viral Therapy in Treating Young Patients With Relapsed or Refractory Solid Tumors

Cixutumumab and Temsirolimus in Treating Younger Patients With Solid Tumors That Have Recurred or Not Responded to Treatment

Temsirolimus, Irinotecan Hydrochloride, and Temozolomide in Treating Younger Patients With Relapsed or Refractory Solid Tumors

R-(-)-Gossypol Acetic Acid, Cisplatin, and Etoposide in Treating Patients With Advanced Solid Tumors or Extensive Stage Small Cell Lung Cancer

Gamma-Secretase Inhibitor RO4929097 in Treating Patients With Metastatic or Unresectable Solid Malignancies

Combination Chemotherapy in Treating Patients With Advanced Solid Tumors

Alvocidib in Treating Patients With Locally Advanced or Metastatic Solid Tumors

SJG-136 in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed By Surgery

Vorinostat and Bortezomib in Treating Patients With Metastatic or Unresectable Solid Tumors

Vorinostat and Alvocidib in Treating Patients With Advanced Solid Tumors

Bevacizumab and Sunitinib in Treating Patients With Solid Tumors

Sorafenib in Treating Patients With Advanced Solid Tumors

Decitabine With or Without Interferon Alfa-2b in Treating Patients With Unresectable or Metastatic Solid Tumors

Sunitinib in Treating Young Patients With Refractory Solid Tumors

Dimethylxanthenone Acetic Acid in Treating Patients With Solid Tumors

Chemotherapy in Treating Patients With Solid Tumors

Irinotecan in Treating Patients With Advanced Solid Tumors

PNU 166148 in Treating Patients With Metastatic Solid Tumors

Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Solid Tumors

SU5416 Combined With Gemcitabine and Cisplatin in Treating Patients With Advanced Solid Tumors

Busulfan, Melphalan, and Antithymocyte Globulin Followed By Umbilical Cord Blood Transplant in Treating Young Patients With Refractory or Relapsed Malignant Solid Tumors

Alvocidib, Oxaliplatin, Fluorouracil, and Leucovorin Calcium in Treating Patients With Advanced Solid Tumors